Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
Published Date:April 30, 1999
Corporate Authors:United States, Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) ; National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.
Keywords:Administration & Dosage
Prevention & Control
Antiviral Agents/Therapeutic Use
Cross Infection/Prevention & Control
Disease Outbreaks/Prevention & Control
Influenza, Human/Drug Therapy
Influenza, Human/Prevention & Control
Influenza Vaccines/Administration & Dosage
Influenza Vaccines/Adverse Effects
Series:MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 48, no. RR-4
Description:"This report updates 1998 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 1998;47[No. RR-6]:1-26). The principal changes include a) information on the influenza virus strains included in the 1999-2000 trivalent vaccine; b) discussion of the potential expanded use of influenza vaccine; c) new background information on live-attenuated influenza vaccines (LAIVs), neuraminidase-inhibitor drugs, and rapid diagnostic tests; d) new information on the epidemiology of influenza among travelers; and e) the addition of referenced citations. This report and other information on influenza can be accessed at the website for the Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC at <http://www.cdc.gov/ncidod/diseases/flu/fluvirus.htm>."
Supporting Files:No Additional Files
You May Also Like: